• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因骨髓移植后晚期移植物失败的分析:利用可变数目串联重复序列位点扩增检测残留宿主细胞

Analysis of late graft failure after allogeneic bone marrow transplantation: detection of residual host cells using amplification of variable number of tandem repeats loci.

作者信息

Nakao S, Nakatsumi T, Chuhjo T, Ohtaguro M, Tsuchiya H, Niki T, Shiobara S, Mori T, Matsuda T

机构信息

Third Department of Medicine, Kanazawa University School of Medicine, Japan.

出版信息

Bone Marrow Transplant. 1992 Feb;9(2):107-11.

PMID:1349248
Abstract

In an attempt to gain insight into the etiology of late graft failure, we analysed the origin of bone marrow mononuclear cells (BMMC) and peripheral blood leukocytes in patients with this syndrome by taking advantage of DNA fragment length polymorphisms in variable number of tandem repeats (VNTR) loci. Amplification of the VNTR loci in DNA from BMMC using the polymerase chain reaction revealed the persistence of host cells in two of four patients studied. One of the patients, whose cultured lymphocytes inhibited in vitro growth of donor-derived hemopoietic progenitor cells, responded to immunosuppressive therapy and donor-derived hemopoiesis was restored. In the other patient, host-derived polymorphonuclear leukocytes (PMN) appeared together with donor-derived PMN from the early post-transplant period, and he proceeded to relapse with myelodysplastic syndrome. In the other two patients in whom host cells were not detectable, the marrow hypoplasia was associated with chronic graft-versus-host disease (GVHD). The hypoplasia improved significantly as the chronic GVHD improved in response to immunosuppressive therapy. We conclude that detecting minimal residual host cells by means of amplification of VNTR loci is valuable for understanding the etiology of late graft failure in marrow transplant recipients, and could prove helpful for choosing appropriate therapy for this syndrome.

摘要

为深入了解晚期移植失败的病因,我们利用可变串联重复序列(VNTR)位点的DNA片段长度多态性,分析了该综合征患者骨髓单个核细胞(BMMC)和外周血白细胞的来源。使用聚合酶链反应对BMMC中的DNA进行VNTR位点扩增,结果显示,在研究的4例患者中有2例存在宿主细胞残留。其中1例患者,其培养的淋巴细胞抑制供体来源的造血祖细胞的体外生长,经免疫抑制治疗后有反应,供体来源的造血功能得以恢复。另一例患者,移植后早期宿主来源的多形核白细胞(PMN)与供体来源的PMN同时出现,随后发展为骨髓增生异常综合征复发。另外2例未检测到宿主细胞的患者,骨髓发育不全与慢性移植物抗宿主病(GVHD)有关。随着免疫抑制治疗后慢性GVHD的改善,骨髓发育不全也明显改善。我们得出结论,通过VNTR位点扩增检测微量残留宿主细胞,对于理解骨髓移植受者晚期移植失败的病因很有价值,并且可能有助于为该综合征选择合适的治疗方法。

相似文献

1
Analysis of late graft failure after allogeneic bone marrow transplantation: detection of residual host cells using amplification of variable number of tandem repeats loci.异基因骨髓移植后晚期移植物失败的分析:利用可变数目串联重复序列位点扩增检测残留宿主细胞
Bone Marrow Transplant. 1992 Feb;9(2):107-11.
2
Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.通过高变DNA区域扩增早期检测骨髓植入。
Haematologica. 1997 Mar-Apr;82(2):156-60.
3
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.异基因淋巴细胞造血移植后完全和混合供体嵌合体的建立:2001年国际骨髓移植登记处与美国血液和骨髓移植学会联合会议上一个研讨会的建议
Biol Blood Marrow Transplant. 2001;7(9):473-85. doi: 10.1053/bbmt.2001.v7.pm11669214.
4
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.通过聚合酶链反应(PCR)对急性白血病患者混合造血嵌合体进行系列定量分析,有助于预测异基因骨髓移植后的复发情况。
Bone Marrow Transplant. 1998 Mar;21(5):487-95. doi: 10.1038/sj.bmt.1701119.
5
Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation.应用聚合酶链反应监测异基因骨髓移植后的植入情况。
Bone Marrow Transplant. 1990 Dec;6(6):399-403.
6
[Clinical application of gene technology to monitor bone marrow transplantation].基因技术在监测骨髓移植中的临床应用
Rinsho Byori. 1994 Mar;42(3):249-56.
7
Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.一名接受第二次异基因骨髓移植治疗严重再生障碍性贫血的患者中供体细胞的白血病转化。
Bone Marrow Transplant. 2002 Mar;29(5):453-6. doi: 10.1038/sj.bmt.1703372.
8
The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.B 系急性淋巴细胞白血病异基因干细胞移植后,急性和慢性移植物抗宿主病对正常及恶性 B 淋巴细胞前体的影响
Haematologica. 2006 Mar;91(3):340-7.
9
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
10
Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.在接受含有固定少量T细胞的骨髓移植的患者中实现了完全供体T细胞嵌合。
Bone Marrow Transplant. 1996 Aug;18(2):389-95.

引用本文的文献

1
Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines.超越嵌合体分析:追踪新一代细胞疗法药物的方法
Bone Marrow Transplant. 2020 Jul;55(7):1229-1239. doi: 10.1038/s41409-020-0822-8. Epub 2020 Feb 5.
2
Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.异基因干细胞移植后复发白血病采用大剂量化疗继以输注外周血干细胞及剂量递增供体淋巴细胞的前瞻性试验。
Int J Hematol. 2005 Dec;82(5):449-55. doi: 10.1532/IJH97.05086.